Controlled dangerous substances; terms; pain management clinics; Oklahoma Bureau of Narcotics and Dangerous Drugs Control; exemptions; registration procedures; compliance; suspension; licensed prescriber; designated administrator; operations requirements; infection control; data collection; reporting; written policy; investigation by Bureau; penalties; rules; effective date.

HB 2148 regulates pain management clinics in Oklahoma that prescribe opioids, benzodiazepines, barbiturates, or carisoprodol for chronic nonmalignant pain (pain lasting over 90 days unrelated to cancer). It requires these clinics to register with the Oklahoma Bureau of Narcotics, meet ownership standards (51% physician-owned or hospital-run), and avoid staff with revoked DEA licenses or drug-related felony convictions. Clinics failing to comply face registration suspension (up to one year) or revocation, with owners barred from operating new clinics for one year after revocation. The bill directly affects clinics meeting its definition - advertising pain services and prescribing controlled substances to over 50% of non-hospice patients for long-term pain.